Promotion & Advertising Policy Work Is On OC Agenda; Will PAPS Be Revived?
This article was originally published in The Gray Sheet
Executive Summary
Device promotion and advertising policy development will be a key focus for CDRH's Office of Compliance during fiscal 2004, according to Director Timothy Ulatowski
You may also be interested in...
Trial Rethink: New Medical Journal Paradigm Should Factor Into Study Plans
Firms may need to become more selective in deciding which trials to conduct if a barrage of negative results are to be avoided, Robert Klepinski, president of Klepinski and DuVal, advised during a recent Regulatory Affairs Professionals Society meeting in Washington, D.
Trial Rethink: New Medical Journal Paradigm Should Factor Into Study Plans
Firms may need to become more selective in deciding which trials to conduct if a barrage of negative results are to be avoided, Robert Klepinski, president of Klepinski and DuVal, advised during a recent Regulatory Affairs Professionals Society meeting in Washington, D.
Device DTC Draft Guidance To Be Released As Part Of FDA Consumer Initiative
FDA's upcoming draft guidances on direct-to-consumer advertising will encourage more use of disease awareness ads, Associate Commissioner for External Relations Peter Pitts said Jan. 23 in a speech to the advocacy group Families USA in Washington, D.C